<DOC>
	<DOCNO>NCT00925977</DOCNO>
	<brief_summary>A randomize , crossover , open study order compare treatment satisfaction insulin Glargine plus insulin Apidra Vs NPH insulin plus insulin Apidra newly diagnose child adolescent type 1 diabetes . The study include two consecutive period : 2 week run period 24 week intervention period , divide two separate treatment period 12 week . According randomization , patient treat consecutively treatment arm : 12 week insulin Glargine 12 week NPH insulin 12 week insulin NPH ad 12 week insulin Glargine . Patients complete DTSQ ( Diabetes Treatment Satisfaction Questionnaire ) month 0 , 12 24 week , end study arm .</brief_summary>
	<brief_title>Treatment Satisfaction Insulin Glargine Plus Insulin Apidra Compared With NPH Insulin Plus Insulin Apidra Recently Diagnosed Type 1 Diabetes Children Adolescents</brief_title>
	<detailed_description>A randomize , crossover , open study order compare treatment satisfaction insulin Glargine plus insulin Apidra Vs NPH insulin plus insulin Apidra newly diagnose child adolescent type 1 diabetes . 134 Patients new onset Diabetes type 1 , diagnose 12 month previously maximum enrol . The study include two consecutive period : 2 week run period 24 week intervention period , divide two separate treatment period 12 week . According randomization , patient treat consecutively treatment arm : 12 week insulin Glargine 12 week NPH insulin 12 week NPH insulin 12 week insulin Glargine . The study consist 4 clinical visit , take place -2 , 0 , 12 24 week . Height , weight , vital sign , HbA1c insulin dos determine clinical visit . Patients complete DTSQ ( Diabetes Treatment Satisfaction Questionnaire ) month 0 , 12 24 week , end study arm . The DTSQ questionnaires consist DTSQ parents- patient age 13 , DTSQ teen age 13 .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Isophane insulin , beef</mesh_term>
	<mesh_term>Insulin glulisine</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Isophane Insulin , Human</mesh_term>
	<mesh_term>Insulin , Isophane</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>1 . Type 1 diabetes diagnose less 12 month prior study entry 2 . Age : 720 year old . 3 . HbA1c &gt; /=8.0 4 . Signing inform consent form 1 . Any significant disease condition , include psychiatric disorder opinion investigator likely effect compliance ability complete study . 2 . Patients participate device drug study . 3 . Any contraindication insulin glargine insulin Apidra Insulin NPH accord SmPC . 4 . Inability , adolescent parent , understand/complete Treatment satisfaction questionnaire .</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>20 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>treatment satisfaction</keyword>
	<keyword>insulin Glargine</keyword>
	<keyword>insulin Apidra</keyword>
	<keyword>NPH insulin</keyword>
</DOC>